21246384

Source:http://linkedlifedata.com/resource/pubmed/id/21246384

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009429, umls-concept:C0017431, umls-concept:C0019196, umls-concept:C0205466, umls-concept:C0439230, umls-concept:C0556895, umls-concept:C0681890, umls-concept:C0871261, umls-concept:C1521761, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	4
pubmed:dateCreated	2011-4-18
pubmed:abstractText	Treatment of genotype 1b chronic hepatitis C virus (HCV) infection has been improved by extending peg-interferon plus ribavirin combination therapy to 72 weeks, but predictive factors are needed to identify those patients who are likely to respond to long-term therapy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9430794
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/NS-5 protein, hepatitis C virus, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/Viral Nonstructural Proteins, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1435-5922
pubmed:author	pubmed-author:ChayamaKazuakiK, pubmed-author:HayesC NelsonCN, pubmed-author:HiasaYoichiY, pubmed-author:IzumiNamikiN, pubmed-author:KumadaHiromitsuH, pubmed-author:MatsumotoAkihiroA, pubmed-author:MoriwakiHisatakaH, pubmed-author:NomuraHideyukiH, pubmed-author:OkanoueTakashiT, pubmed-author:OketaniMakotoM, pubmed-author:SakisakaShotaroS, pubmed-author:SeikeMasatakaM, pubmed-author:TakeharaTetsuoT, pubmed-author:ToyotaJojiJ, pubmed-author:UenoYoshiyukiY, pubmed-author:YoshiokaKentaroK, pubmed-author:YotsuyanagiHiroshiH
pubmed:issnType	Electronic
pubmed:volume	46
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	545-55
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21246384-Adult, pubmed-meshheading:21246384-Age Factors, pubmed-meshheading:21246384-Aged, pubmed-meshheading:21246384-Amino Acid Substitution, pubmed-meshheading:21246384-Antiviral Agents, pubmed-meshheading:21246384-Data Mining, pubmed-meshheading:21246384-Decision Trees, pubmed-meshheading:21246384-Drug Therapy, Combination, pubmed-meshheading:21246384-Female, pubmed-meshheading:21246384-Follow-Up Studies, pubmed-meshheading:21246384-Genotype, pubmed-meshheading:21246384-Hepacivirus, pubmed-meshheading:21246384-Hepatitis C, Chronic, pubmed-meshheading:21246384-Humans, pubmed-meshheading:21246384-Interferon-alpha, pubmed-meshheading:21246384-Logistic Models, pubmed-meshheading:21246384-Male, pubmed-meshheading:21246384-Middle Aged, pubmed-meshheading:21246384-Multivariate Analysis, pubmed-meshheading:21246384-Polyethylene Glycols, pubmed-meshheading:21246384-Predictive Value of Tests, pubmed-meshheading:21246384-Recombinant Proteins, pubmed-meshheading:21246384-Retrospective Studies, pubmed-meshheading:21246384-Ribavirin, pubmed-meshheading:21246384-Sensitivity and Specificity, pubmed-meshheading:21246384-Sex Factors, pubmed-meshheading:21246384-Time Factors, pubmed-meshheading:21246384-Viral Load, pubmed-meshheading:21246384-Viral Nonstructural Proteins
pubmed:year	2011
pubmed:articleTitle	Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C.
pubmed:affiliation	Department of Medical and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. chayama@hiroshima-u.ac.jp
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't